Success Stories

September 2018 Question of the Month

How will the addition of step therapy on Medicare Part B drugs impact biosimilars?

Increase use of biosimilars: 54.55%

No Change: 36.36%

Decrease biosimilar use: 9.09%

Will deeply discounted WAC prices (list price) for biosimilars and specialty generics influence uptake?

Yes: 28.6%

Some impact: 57.1%

No: 14.3%

What is your opinion on pharmacists being allowed to refuse to dispense a prescription for ethical reasons?

Agree: 12.5%

Agree, if they can find another reasonable option for the patient: 56.25%

Disagree: 25%

Indifferent: 6.25%